Efavirenz Completed Phase 3 Trials for Acquired Immune Deficiency Syndrome (AIDS) / Human Immunodeficiency Virus (HIV) Infections

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT00197613The Adult Antiretroviral Treatment and Resistance Study (Tshepo)
NCT00135343A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen